A huge Series A before clear product-market fit creates immense pressure to scale prematurely. This can force 'unnatural acts' and unrealistic expectations, potentially leading the company to implode. It challenges the 'more money is always better' mindset at the early stages.

More startups die from overfunding ("indigestion") than underfunding ("starvation"). Raising too much capital leads to operational indiscipline and sets an extremely high valuation hurdle for the next round. This creates a toxic situation, as new investors almost never want to lead a down round in someone else's company.

Raising too much money at a high valuation puts a "bogey on your back." It forces a "shoot the moon" strategy, which can decrease capital efficiency, make future fundraising harder, and limit potential exit opportunities by making the company too expensive for acquirers.

Qualtrics intentionally raised capital at valuations up to 40% lower than what they were offered. This cap table management strategy ensured their eventual IPO could still be an up-round even in a shaky market, avoiding the morale-crushing impact of a down-round IPO.

Contrary to founder belief, raising too much money is incredibly dangerous. It fosters a lack of discipline and operational "indigestion." A high valuation also sets a dangerous precedent, making future fundraising difficult as new investors are loath to lead a down round, effectively trapping the company.

An investor passed on a fund that paid 30-40x revenue for startups, believing quality alone justifies price. Three years later, that fund and its predecessors are underwater. This illustrates that even for great companies, undisciplined entry valuations and the assumption of multiple expansion can lead to poor returns.

The founder consciously avoided raising at a high valuation, not just to prevent a future down round, but because he saw it as a source of immense psychological pressure. He felt this pressure would distract from solving hard, long-term problems, preferring a shorter runway to the mental burden of an inflated valuation.

Accepting too high a valuation can be a fatal error. The first question in any subsequent fundraising or M&A discussion will be about the prior round's price. An unjustifiably high number immediately destroys the psychology of the new deal, making it nearly impossible to raise more capital or sell the company, regardless of progress.

Chasing high, unrealized valuations is dangerous. It makes common stock prohibitively expensive, undermining the potential for life-changing wealth for employees—a key recruiting tool. It also narrows a company's strategic options, locking it into a high-stakes path where anything less than exceeding the last valuation is seen as failure.